# Sources — Voltaire

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Pomeau RH. “Voltaire.” *Encyclopaedia Britannica*. Gives him as the pseudonym of François-Marie Arouet, “Born: November 21, 1694, Paris”, “Died: May 30, 1778, Paris (aged 83)”; “According to his birth certificate he was born on November 21, 1694, but … he stated on several occasions that in fact it took place on February 20”; his putative father François Arouet, who “became receiver in the Cour des Comptes”; his mother, “Having lost her when he was seven”; his imprisonment “in the Bastille for nearly a year (1717)”; and that he was beaten, taken to the Bastille, “and then conducted to Calais on May 5, 1726, whence he set out for London.” https://www.britannica.com/biography/Voltaire
2. Pomeau RH. “Voltaire: Achievements at Ferney.” *Encyclopaedia Britannica*. “he made his triumphal return to the city he had not seen for 28 years on February 10. More than 300 persons called on him the day after his arrival. On March 30 he went to the Académie amid acclamations, and, when Irène was played before a delirious audience, he was crowned in his box. His health was profoundly impaired by all this excitement. On May 18 he was stricken with uremia. He suffered much pain on his deathbed, about which absurd legends were quickly fabricated; on May 30 he died, peacefully it seems”; his burial at the Abbey of Scellières and later transfer to the Panthéon. https://www.britannica.com/biography/Voltaire/Achievements-at-Ferney
3. Voltaire Foundation, University of Oxford. “About Voltaire.” “François-Marie Arouet (1694-1778), known as Voltaire”; “Born in Paris into a wealthy bourgeois family”; in 1718 “he invented a new name for himself”; in February 1778 his return to Paris to stage *Irène*, “the first time he had set foot in the capital since 1750”; “despite his deteriorating health” he attended the performance; “His health did not permit his return to Ferney, and he died in Paris two months later.” https://www.voltaire.ox.ac.uk/about-voltaire/
4. Voltaire. Letter to the baron de Breteuil, December 1723 (Correspondance, Garnier edition, letter 101). Wikisource. “Je vais vous obéir, monsieur, en vous rendant un compte fidèle de la petite vérole dont je sors”; “nous fûmes indisposés le 4 novembre dernier” at Maisons; the disease declared itself “après deux jours de fièvre, et s’annonça par une légère éruption”; “M. de Gervasi, médecin de M. le cardinal de Rohan”; “Il fut obligé de me faire prendre huit fois l’émétique”, “il me fit boire deux cents pintes de limonade”; “Je me fis saigner une seconde fois de mon autorité”; “J’étais le 15 absolument hors de danger.” https://fr.wikisource.org/wiki/Correspondance_de_Voltaire/1723/Lettre_101
5. Lachèvre F. *Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie*. Paris: Champion; 1908. Internet Archive. An anonymous, hostile manuscript of 1778 with the editor's notes, which quote Wagnière's account, Gaultier's memoir, and the autopsy report. Wagnière: “Le 25 février, à midi et un quart, il me dictait de son lit. Il toussa trois fois assez fort … Oh ! oh ! je crache le sang. Et sur le moment, le sang lui jaillit par la bouche et par le nez”; his declaration of 2 March, “étant attaqué depuis 4 jours d'un vomissement de sang à l'âge de 84 ans”; the editor: “Voltaire, atteint de strangurie, avait besoin d'être sondé souvent et cette partie du traitement incombait à Try”; the manuscript: he took “jusqu'à dix-huit tasses” of coffee before an Académie meeting, the maréchal de Richelieu's “petite bouteille d'un opium préparé” which he took “en une seule fois au lieu de la diviser en trois ou quatre doses”, and “La vessie, autant remplie de pus que d'urine, ne pouvoit être dégagée que par le cruel service d'une sonde à canal”; Wagnière on the apothecary's liquor of 11 or 12 May and the request for Richelieu's opium; and the “Rapport de l'ouverture et embaumement du corps de M. de Voltaire fait le trente et un may 1778”, signed by Try: “le cerveau et le cervelet très sains, les viscères de la poitrine en très bon état”; “la vessie étoit décomposée, elle avait acquis l'épaisseur de plus d'un pouce à la partie supérieure et postérieure … semblable à du lard”, with suppurating tubercles leaking into the abdomen; the right kidney “taché de marques gangreneuses”; “La glande prostate étoit très volumineuse, et entièrement squireuse.” https://archive.org/details/voltairemourante00lachuoft
6. Julien P. “Les maladies et la mort de Voltaire: Jean Orieux, Voltaire ou la Royauté de l'esprit” [review]. *Revue d'histoire de la pharmacie* 1970;58(204):60-61. Persée. Summarizing Orieux: “Il souffre de la colique”; “Il lui arrive de prendre en un mois huit purges et douze lavements”; “Il est persuadé qu'il mourra avant quarante ans”; “Il souffrait réellement des reins et de la vessie. Et le 13 mai 1778 … il se mit au lit”; he refused a neighboring apothecary's potion but accepted the one the duc de Richelieu brought, “qui était à base d'opium”, after which “Il fut parcouru par une traînée de feu de la gorge aux entrailles. Il devint forcené”; “Voltaire mourut pour ainsi dire seul le 30 mai 1778”; “Le corps fut autopsié.” https://www.persee.fr/doc/pharm_0035-2349_1970_num_58_204_7976_t1_0060_0000_1
7. Russell A. “Voltaire's thoughts on death.” OUPblog, Oxford University Press, 29 May 2018. Quotes his letter of 1769: “Yes, sir, it is true that I have been very ill. … But that is the common lot of old age, especially when one has always had a feeble constitution”; dates his smallpox to December 1723. https://blog.oup.com/2018/05/voltaire-death/
8. Charlier P, Neuzillet Y, Le Gendre R, Armengaud J. “Paleoproteomic study of blood residues shows that Voltaire (1778) died of perforated bladder squamous cell cancer with peritoneal extension.” *BJU Int* 2025;136(6):1002-1003. PMID 40977402 (bibliographic record only; no abstract; the article was not read). https://pubmed.ncbi.nlm.nih.gov/40977402/
9. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. Barocas DA, et al. “Microhematuria: AUA/SUFU Guideline.” *J Urol* 2020;204(4):778-786 (PMID 32698717), amended as “Updates to Microhematuria: AUA/SUFU Guideline (2025).” *J Urol* 2025;213(5):547-557 (PMID 40013563). The 2025 unabridged text notes that “most experts agree that patients with GH should be evaluated with cystoscopy, upper tract imaging and urinary cytology”; history of gross hematuria and age are high-risk features; for high-risk patients “clinicians should perform multiphasic CT urography (including imaging of the urothelium)” and white light cystoscopy. https://www.auanet.org/guidelines-and-quality/guidelines/microhematuria
2. Holzbeierlein J, et al. “Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024).” *J Urol* 2024;212(1):3-10. PMID 38661067. https://pubmed.ncbi.nlm.nih.gov/38661067/
3. National Comprehensive Cancer Network. *NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer*, Version 3.2026, including non-urothelial and subtype histologies. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1417
4. European Association of Urology. *EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer*. https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer
5. Hafeez S, et al. “Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.” *Int J Radiat Oncol Biol Phys* 2017;98(1):115-122. PMID 28586948. The weekly regimen of 36 Gy in six fractions is the one used in the later multicentre trial for patients with T2-T4a N0 M0 disease unsuitable for cystectomy or daily radiotherapy (Hafeez S, et al. *BMJ Open* 2020;10:e037134, PMID 32461298). https://pubmed.ncbi.nlm.nih.gov/28586948/
6. Sandhu JS, et al. “Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.” *J Urol* 2024;211(1):11-19. PMID 37706750. https://pubmed.ncbi.nlm.nih.gov/37706750/
7. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), urologic cancer and benign prostatic hyperplasia monographs. BPH: IPSS at baseline and every follow-up; post-void residual when retention is suspected; DRE at baseline; PSA when it would change management; reassessment 4 to 12 weeks after an alpha-blocker. Bladder cancer: risk-stratified cystoscopy and cytology surveillance for NMIBC and CT surveillance after cystectomy. https://patrickrutledge.github.io/topthirty/
8. Hooton TM, et al. “Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.” *Clin Infect Dis* 2010;50(5):625-663. PMID 20175247. https://pubmed.ncbi.nlm.nih.gov/20175247/
9. Dowell D, et al. “CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022.” *MMWR Recomm Rep* 2022;71(3):1-95. PMID 36327391. https://pubmed.ncbi.nlm.nih.gov/36327391/
10. American Geriatrics Society Beers Criteria Update Expert Panel. “American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.” *J Am Geriatr Soc* 2023;71(7):2052-2081. PMID 37139824. https://pubmed.ncbi.nlm.nih.gov/37139824/
11. Mohile SG, et al. “Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.” *J Clin Oncol* 2018;36(22):2326-2347. PMID 29782209. https://pubmed.ncbi.nlm.nih.gov/29782209/
12. Medicare Preventive Services reference (Aether Forge, 2026); CDC Adult Immunization Schedule by Age (2026); and U.S. Preventive Services Task Force recommendations on prostate cancer screening (2018), colorectal cancer screening (2021), falls prevention in older adults (2024), abdominal aortic aneurysm screening (2019), and unhealthy alcohol use (2018). https://patrickrutledge.github.io/preventative_services/ and https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html and https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening

## Editorial resolutions

- **Name.** He was born François-Marie Arouet and took the name Voltaire in 1718; he signed, published, and was known by it for sixty years. The display name is “Voltaire”, and `identity.name_parts` places that single name in the family-name field with an empty given array, as other single-name records do, so that C-CDA and FHIR do not split it or substitute a birth name he did not use. The birth name “François-Marie Arouet” is recorded as the alias; grep found it in no other record. The notes call him Voltaire, without “Mr.”
- **Calendar and dates.** France used the Gregorian calendar throughout his life, so no conversion is needed. His birth certificate gives 21 November 1694, which the record uses; his own repeated claim of 20 February is recorded as a conflicting alternative. The synthetic date of birth is November 21, 1942, so the whole-year shift is 248 years and 2026 maps to 1778.
- **Index age and dates; a compressed schedule.** The episode presents him at 83, in Paris, on April 6, 2026 (true frame 6 April 1778): after his return to Paris (10 February), the bleeding from the mouth and nose (25 February), and his acclaim at the Académie (30 March), and before the documented terminal illness of mid-May. Every visit had to fall before his death on 30 May 1778, and none was placed after he took to his bed (about 13 May), so the whole episode runs over one month: index April 6; CT urography April 8; focused visit and urology consultation April 13 (true 13 April); resection April 15; sick visit April 20; focused visit April 22; wellness visit April 28; radiotherapy from April 29; last focused visit May 6 (true 6 May 1778). The full visit structure fits: three chronic-care visits, a sick visit, a wellness visit, and the consultation at visit 2. Goal target dates were set no later than May 27. Radiotherapy is recorded as in progress after two of six fractions; its planned completion would fall after his true death date and is not recorded.
- **Presenting problem and diagnosis.** The intake problem is gross hematuria with difficult urination (R31.0), resolved on April 22, 2026, when the resection pathology gives the diagnosis. Chronic retention (R33.8) and acute kidney injury from obstruction (N17.9, resolved at visit 2) are known at intake. Benign prostatic hyperplasia (N40.1) is recorded at visit 2 and the bladder cancer (C67.4) at visit 3. Intake documents show only what was known at intake.
- **Which diagnosis, and why.** The 1778 autopsy describes a bladder more than an inch thick at its upper and posterior part, lard-like, with suppurating tubercles leaking into the abdomen, and a very large, entirely hard prostate (D). The most recent peer-reviewed reading (Charlier and colleagues, *BJU International*, 2025) is a perforated squamous cell carcinoma of the bladder; Britannica gives uremia; prostate cancer is also suggested by the “scirrhous” prostate, though no reputable source read argues it. The modern episode follows the bladder evidence: a muscle-invasive, keratinizing squamous cell carcinoma of the posterior wall and dome (cT3b N0 M0), with benign prostatic hyperplasia and chronic retention, and it deliberately does not diagnose prostate cancer (PSA 6.4 ng/mL with a PSA density of 0.08 and a smooth gland; no MRI or biopsy by shared decision, because the finding would not change care at 83). The historical cause of death remains **R**, disputed (CLM-0012); the record asserts none as his historical diagnosis. The 2025 article could not be read (no abstract; publisher page blocked); only its title and bibliographic data are used. Pure squamous cell carcinoma is uncommon where schistosomiasis is not endemic; the record states this and lists the risk factors that were asked about and absent, and does not invent bladder stones.
- **Treatment choice.** After a geriatric assessment (G8 11 of 17, BMI 18.5, independent in self-care, needing help with shopping and travel), cystectomy, daily bladder-preserving radiotherapy, weekly palliative radiotherapy, and symptom care were discussed. He chose weekly hypofractionated radiotherapy, 36 Gy in six fractions (the regimen of Hafeez and colleagues for patients unsuitable for radical treatment), with early palliative care, because his goals were to stay at home, keep writing, and avoid long hospital stays. No chemotherapy is given, because squamous histology responds poorly and his kidney function and frailty argue against it.
- **Opium, opioids, and the medication review.** Accounts agree that he took a large dose of an opium preparation in mid-May 1778 (CLM-0008, **D**, sensitive), after the index date. The modern episode does not place that event in his past; it echoes it only in the safety plan: a friend's offer of opium drops is refused, and the clinic prescribes scheduled acetaminophen with oxycodone 2.5 mg as needed (no more than three doses a day, 15 tablets, one prescriber), naloxone, senna, a prescription monitoring program check, a locked box, and review in two weeks (CDC 2022). The intake medication review stops a nightly diphenhydramine sleep aid, which can cause retention (AGS Beers 2023), and over-the-counter sodium phosphate enemas, which are unsafe with reduced kidney function; these echo his documented self-medication and purges without asserting them.
- **What was verified and what was not.** Smallpox with onset on 4 November 1723 is **D** from his own letter; the OUP blog's “December 1723” is the date of the letter, and the brief's “November 1723” is correct. The bleeding of 25 February 1778, strangury with catheterization, the opium episode, and the autopsy findings are **D** from Lachèvre's 1908 edition. Lachèvre's main text is an anonymous, hostile manuscript; its coffee anecdote (eighteen cups) is graded **R**, possible, and the roster's “40 to 50 cups a day” was not found and is left out. The roster's “probable IBD”, “anxiety”, and “insomnia” were not found in any reputable source read and are not used; chronic constipation is the modern echo of the documented colic, purges, and enemas. Legends about his deathbed, which Britannica calls fabricated, are not repeated. The Britannica pages could be read only by direct download (WebFetch was refused).
- **The bleeding from the mouth and nose.** The source of the documented bleeding of February 1778 is unknown. The modern episode records it in the referral as a nosebleed with blood in the mouth after a coughing fit, treated with packing, and the intake CT includes the chest, which is clear (as the autopsy found the chest healthy and the vessel healed). This is a synthetic reading that asserts nothing about the 1778 event.
- **Sick and wellness visits.** The sick visit is a febrile catheter-associated urinary tract infection with *Escherichia coli* five days after the resection, treated with a catheter change and seven days of cefpodoxime (IDSA); it fits his catheter and echoes, without asserting, the infected urine described in his last weeks. The wellness visit is `annual_wellness_subsequent` at 83, with PHQ-2, Mini-Cog, Timed Up and Go, a falls and nutrition plan, vaccines up to date, cancer screening stopped, and advance care planning (a health care agent and a portable medical order) that names no real person.
- **Focused visits.** The three chronic-care follow-ups (one, two and a half, and four and a half weeks after intake) are documented as focused visits on the AUA/SUFU hematuria guideline, the CMID BPH and urologic cancer monographs, the AUA BPH guideline, NCCN, AUA/ASCO/SUO and EAU bladder cancer guidance, ASCO geriatric oncology, IDSA, and the CDC opioid guideline: imaging, cystoscopy, culture and cytology, kidney function after drainage, PSA interpretation, IPSS and post-void residual (recorded as not indicated while the catheter was in), alpha-blocker tolerability, the geriatric assessment, staging, pain scores, opioid start and follow-up, radiation toxicity, and nutrition. The CMID surveillance schedules for NMIBC and after cystectomy are recorded as not indicated, with the reason. One deviation is recorded as `deferred`, with its outcome and corrective action, and no result was invented: home physical therapy ordered at the wellness visit had not started by the last visit because the agency had no therapist; he had not fallen, and a second agency was arranged with interim exercises.
- **Consultation.** The urology referral and consultation (Aurelio Bergström-Nwosu, MD, a fictional consultant, on the day of the second visit) are **S**. The consultant performs cystoscopy, finds a solid tumor likely to be muscle-invasive, advises resection under anesthesia, keeps the catheter until then with a later voiding trial on tamsulosin, advises against prostate MRI or biopsy, and frames the treatment options for after the pathology; the record then shows the resection, the voiding trial passed, no prostate biopsy, and the geriatric assessment and treatment choice.
- **Real people.** Wagnière, Gaultier, Tronchin, Try, Richelieu, and the baron de Breteuil appear only in documented history claims. The modern episode names none of them and attributes no decision, statement, or health fact to them or to any relative; his assistant, the colleague he names as health care agent, and the friend who offers drops are unnamed and synthetic.
- **Family and past history.** Only his mother's death when he was seven and his putative father's occupation are recorded (causes not recorded in the cited sources). Past medical history holds smallpox (1723), lifelong digestive and urinary complaints, and the bleeding of February 1778, all before the true-frame index date. The opium dose, strangury, uremia, death, and autopsy appear only on the timeline after the index date.
- **Primary clinician.** Honorine Delacroix-Mensah, MD, is cast as his primary care physician.
- Voltaire died in 1778, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
